The role of novel antidiabetic drugs in diabetic HFpEF Emerging studies indicated that the novel antidiabetic drugs, including SGLT2i, GLP-1 RA and DPP4i, provided the cardiovascular benefits in diabetic HFpEF patients [45,46,47,48,49]
Monday - Friday: 8:30 am-5:30 pm Walk-ins are welcome
Consumers taking insulin saved more than $18 million with point-of-sale discounts in 2022 alone, part of more than $45 million in member savings on insulin since the program launched
Acetyl-L-carnitine (ALCAR) is an acetylated form of L-carnitine that crosses the blood-brain barrier more effectively than standard L-carnitine
Footnotes AUTHOR DISCLOSURE STATEMENT The authors declare no conflict of interest
These combined effects create a favorable environment for healing without directly altering structural anatomy